Select a service area View all services (A-Z listing)
Use one of the following options to find your doctor at Cabrini
or
Malvern
Brighton

Looking for a physiotherapist or other professional? See Allied Health

Federal Government funding boost for Monash Partners

Date: 16/05/2017

 

As a member of Monash Partners Academic Health Science Centre, Cabrini shares in the honour of being recognised as one of just four Advanced Health Research and Translation Centres (AHRTC) in Australia – an accolade that recognises the collaboration's capability to improve the community's health outcomes through high impact, translational research.

Translational research is defined as the application of findings from basic science to enhance human health and wellbeing. It is the process of taking research from the bench to the bedside and transforming breakthroughs into clinical applications on an appropriate scale.
According to Monash Partners, the health of Victorians and Australians is set to improve with the announcement of significant Federal Government investment to support AHRTCs. These leading centres are accredited by the National Health and Medical Research Council https://www.nhmrc.gov.au to conduct rapid transformational research that delivers solutions to health service problems, with direct patient benefits. 
An investment of $10m was announced last week (8 May 2017) by the Australian Government. Initially, this investment will be focused across accredited centres including Alfred Health and Monash Health & Partners (Monash Partners). 
Monash Partners directly integrates research, education and clinical care around a vision to improve the health of the community and encompasses Alfred Health, Monash Health, Baker Institute, Burnet Institute, Cabrini, Eastern Health, Epworth HealthCare, Hudson Institute, Monash University and Peninsula Health. Monash Partners will receive more than $2m as part of a formative investment to support world-leading research to underpin high quality healthcare improvement and better health outcomes.
Executive Director of Monash Partners, Professor Helena Teede, welcomed the announcement, saying these funds will support a wide range of translational research projects responsive directly to the needs of the communities, health providers and health services that will deliver direct clinical benefits.
Projects such as the Monash Partners Lung Cancer Care Improvement project address Australia’s number one cancer killer: lung cancer. With treatment options changing rapidly, monitoring and quality of lung cancer care will be improved to ensure that all Victorians have access to the best possible care, whether they are treated in cities, regional or rural areas. This initiative will improve the care, health and quality of life for those with lung cancer. 
“Using innovative approaches to address the biggest challenges currently facing healthcare provision in Victoria and Australia, Monash Partners represents a world leading, powerful collaboration between some of the best health researchers, leading clinicians and educators and the community who are both the funders and ultimate recipients of benefits from health and research investment,” Professor Teede said. “This important funding enables Monash Partners’ to collaboratively deliver consistent, high quality healthcare for our communities, supported by world-leading research and an exceptional well trained clinical workforce.”
About Monash Partners
Monash Partners is an innovative health service, research and educational collaboration. Established in 2011, the partnership was officially accredited as one of four world leading Advanced Health Research and Translation Centres in 2015 by the National Health and Medical Research Council. Monash Partners has also played a leading role in the National Alliance of Centres to drive unprecedented national collaboration, deliver impact from research and drive better health outcomes. 
Monash Partners comprises ten independent, world class providers of health focused services, research and education in Victoria. It builds on similar models of successful academic health centres developed in Europe, the United Kingdom and the USA, but differs as it is health service-led and community benefit-focused. 
For more information visit:
http://www.monash.edu/news/articles/monash-partners-receives-funding-boost-in-federal-budget-with-health-benefits-to-victorians 
https://www.monashpartners.org.au/News-and-Events/Monash-Partners-receives-a-significant-funding-boost-in-the.aspx 

As a member of Monash Partners Academic Health Science Centre, Cabrini shares in the honour of being recognised as one of just four Advanced Health Research and Translation Centres (AHRTC) in Australia – an accolade that recognises the collaboration's capability to improve the community's health outcomes through high impact, translational research.

Translational research is defined as the application of findings from basic science to enhance human health and wellbeing. It is the process of taking research from the bench to the bedside and transforming breakthroughs into clinical applications on an appropriate scale.

According to Monash Partners, the health of Victorians and Australians is set to improve with the announcement of significant Federal Government investment to support AHRTCs. These leading centres are accredited by the National Health and Medical Research Council https://www.nhmrc.gov.au to conduct rapid transformational research that delivers solutions to health service problems, with direct patient benefits. 

An investment of $10m was announced last week (8 May 2017) by the Australian Government. Initially, this investment will be focused across accredited centres including Alfred Health and Monash Health & Partners (Monash Partners). 

Monash Partners directly integrates research, education and clinical care around a vision to improve the health of the community and encompasses Alfred Health, Monash Health, Baker Institute, Burnet Institute, Cabrini, Eastern Health, Epworth HealthCare, Hudson Institute, Monash University and Peninsula Health. Monash Partners will receive more than $2m as part of a formative investment to support world-leading research to underpin high quality healthcare improvement and better health outcomes.

Executive Director of Monash Partners, Professor Helena Teede, welcomed the announcement, saying these funds will support a wide range of translational research projects responsive directly to the needs of the communities, health providers and health services that will deliver direct clinical benefits.

Projects such as the Monash Partners Lung Cancer Care Improvement project address Australia’s number one cancer killer: lung cancer. With treatment options changing rapidly, monitoring and quality of lung cancer care will be improved to ensure that all Victorians have access to the best possible care, whether they are treated in cities, regional or rural areas. This initiative will improve the care, health and quality of life for those with lung cancer. 

“Using innovative approaches to address the biggest challenges currently facing healthcare provision in Victoria and Australia, Monash Partners represents a world leading, powerful collaboration between some of the best health researchers, leading clinicians and educators and the community who are both the funders and ultimate recipients of benefits from health and research investment,” Professor Teede said. “This important funding enables Monash Partners’ to collaboratively deliver consistent, high quality healthcare for our communities, supported by world-leading research and an exceptional well trained clinical workforce.”

About Monash Partners

Monash Partners is an innovative health service, research and educational collaboration. Established in 2011, the partnership was officially accredited as one of four world leading Advanced Health Research and Translation Centres in 2015 by the National Health and Medical Research Council. Monash Partners has also played a leading role in the National Alliance of Centres to drive unprecedented national collaboration, deliver impact from research and drive better health outcomes. 

Monash Partners comprises ten independent, world class providers of health focused services, research and education in Victoria. It builds on similar models of successful academic health centres developed in Europe, the United Kingdom and the USA, but differs as it is health service-led and community benefit-focused. 

For more information visit:

http://www.monash.edu/news/articles/monash-partners-receives-funding-boost-in-federal-budget-with-health-benefits-to-victorians 

https://www.monashpartners.org.au/News-and-Events/Monash-Partners-receives-a-significant-funding-boost-in-the.aspx